STOXX 600Health Care· Denmark

NOVO-B

Status-Quo-Player

Novo Nordisk

$260.40

+1.24%

Open $257.20·Prev $257.20

as of 17 Apr

STATUS-QUO-PLAYER

Power Core

Novo Nordisk's moat is the compounding integration of GLP-1 molecular leadership, proprietary manufacturing scale, and chronic disease lock-in.

Published18 Apr 2026

UniverseSTOXX 600

SectorHealth Care

→

Direction of Movement

lateral

ROC 200

-42.9%